A retrospective study was performed of an 11 year period 
Barrett's oesophagus'2 represents a metaplastic transformation of the normal squamous cell epithelium of the lower tubular oesophagus into columnar epithelium. 3 The premalignant character of Barrett's oesophagus is shown by a progession from benign columnar epithelium into dysplasia and adenocarcinoma.45 Although endoscopic surveillance and biopsy are performed to achieve an early diagnosis of malignant degeneration, many patients with Barrett's oesophagus present primarily with symptoms of an oesophageal carcinoma.
The survival of patients with an adenocarcinoma in Barrett's oesophagus is low, even after oesophagectomy.67 The influence of infiltration of the oesophageal wall, lymph node metastases, and the histological grade of the tumour on the prognosis is not fully understood. This retrospective study aimed to analyse the survival of patients with an adenocarcinoma in columnar lined oesophagus in relation to surgical treatment, staging, and the differentiation grade of the tumour. 
Patients and methods
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SYMPTOMS AND SOCIAL HABITS
The most important presenting symptoms were dysphagia (60%) and pain (25%). The patients' characteristics with respect to symptoms of gastro-oesophageal reflux and treatment are listed in Table II Of all 112 patients with an adenocarcinoma, only 6 (5%) had a previous biopsy proved history of columnar lined oesophagus. The area of adenocarcinoma was circular in 41 patients (36%), and comprised more than half the circumference of the oesophagus in 19 (17%). On average, the tumour covered a length of 5 cm of the distal tubular oesophagus (range 1-12 cm). In the group of patients with a resectable tumour (n= 85) the mean (SD) length of the tumour was 4 (2) cm, and in the group with an unresectable tumour (n=27) it was 6 (2) Slides were reviewed to determine the differentiation grade of the tumour. In two cases the tumour was classified as well differentiated, in 52 as moderately differentiated, and in 58 cases as poorly differentiated.
In 95% of the cases, the margins of the resected specimens were free of tumour tissue on histological examination, but in four cases (5%) microscopical remnants were found.
Patients were classified according to the pTNM classification as shown in Table I 18 from causes unrelated to carcinoma, and in six cases the cause of death was unknown.
Life table analysis showed 1, 2, and 5 year survival rates of 57%, 31%, and 17% respectively for the whole group. The 1, 2, and 5 year survival rates of the 85 patients who underwent oesophagectomy were 67%, 38%, and 24% respectively, and for the 27 inoperable or unresectable patients the figures were 26%, 11%, and 0% respectively (p<0001) (Fig 1) .
Within the group of resected patients (n= 85), there were no significant differences in survival between patients treated by preoperative radiation (n=66) and those treated by resection alone (n= 19). Patients classified as stage 0, I, or IIA (no regional lymph node metastases) had a significantly better survival (p=0.03) with 1, 2, and 5 year survival rates of 76%, 47%, and 30% respectively, compared with patients classified as stage IIB and III (regional lymph node metastases present), with 1, 2, and 5 year survival rates of 44%, 10%, and < 10% respectively (Fig  2) . Patients with a Tis or T1 tumour without regional lymph node involvement (n= 12) had significantly better survival than patients with a T2 or T3 tumour without regional lymph node involvement (n=49), p<0 05 (Fig 3) . Patients with well (GI) or moderately (GII) differentiated tumours classified as stage 0, I, IIA and IIB, III respectively did not show a significant better survival than patients with poorly differentiated (GIII) tumours (Fig 4) . 20 Tis, T1; (n = 12) phagus is about 57 years and the male to female l T2, T3; (n = 49) ratio is 55: 1.'3 In our series, the mean age was higher (63 years), and the male to female ratio will not inevitably lead to regression or resolution of Barrett's epithelium, and may not reduce the risk of malignant degeneration. The treatment of choice most often reported for adenocarcinoma of the oesophagus is surgery.7 1617 The reported postoperative mortality after oesophagectomy for carcinoma varies between 10 and 16%.7 181 9 Most of these studies, however, comprised patient populations treated by varying surgical techniques, in the period before our study. While most patients with an adenocarcinoma associated with Barrett's oesophagus are resectable, the long term survival is low.7 In our series the 5 year overall survival was 17%, and after resection and reconstruction it was 24%, which agrees with the reported 5 year survival (14-5-22%).7 17 Seventy two per cent of the resected patients did not have lymph node involvement, and more than one third (36%) had neither node involvement nor full thickness penetration of the oesophageal wall, which has been reported as favourable.78
A clear correlation between the pathological staging of oesophageal tumours and prognosis has been reported -infiltration through the muscular wall and regional lymph node metastases, in particular, have a negative influence on survival rates. '8202' Within the group of resected patients in our series, those without regional lymph node metastases showed significantly better survival than patients with regional lymph node metastases. Survival was significantly better in patients whose tumour was restricted to the submucosa and had not invaded the muscle layer.
The influence of the histological differentiation grade of adenocarcinomas in Barrett 
